. may 16, 2018
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Lawford-daughter-of-Schabowski-from-Edmonton?Trestgran=125
.
.
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened. . .